Y-mAbs Therapeutics Q3 EPS $(0.7) Misses $(0.55) Estimate

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.7) per share which missed the analyst consensus estimate of $(0.55) by 27.27 percent. This is a 66.67 percent decrease over losses of $(0.42) per share

Benzinga · 11/13/2019 21:01

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.7) per share which missed the analyst consensus estimate of $(0.55) by 27.27 percent. This is a 66.67 percent decrease over losses of $(0.42) per share from the same period last year.